Dercum’s Disease Market Research Report: by Treatment (Surgery, Medication, Liposuction, Electrotherapy, Acupuncture, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-User (Hospital & Clinics, Others) - Forecast Till 2027

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Dercum’s Disease Market, by Treatment

6.1 Introduction

6.2 Surgery

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3 Medication

6.3.1 Diuretics

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.2 Non-Steroidal Anti-Inflammatory Drugs

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.3 Corticosteroids

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.4 Others

6.4 Liposuction

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.5 Electrotherapy

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.6 Acupuncture

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.7 Others

Chapter 7. Global Dercum’s Disease Market, by Distribution Channel

7.1 Introduction

7.2 Retail Pharmacies

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

7.3 Hospital Pharmacies

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

7.4 Others

Chapter 8. Global Dercum’s Disease Market, by End-User

8.1 Introduction

8.2 Hospital & Clinics

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8.4 Others

Chapter 9. Global Dercum’s Disease Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Pfizer, Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 AbbVie, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Merck & Co., Inc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Johnson & Johnson Services, Inc.

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 GlaxoSmithKline plc

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Novartis

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Acorda Therapeutics, Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 F. Hoffman La Roche AG

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Eli Lily and Company

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 AstraZeneca Plc

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Amgen

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Valeant Pharmaceuticals

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Syneron Medical

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 St. Jude Medical Inc.

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Alimed Inc.

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Dercum’s Disease Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Dercum’s Disease Market Synopsis, 2019–2027

Table 2 Global Dercum’s Disease Market Estimates and Forecast, 2019–2027 (USD Million)

Table 3 Global Dercum’s Disease Market, by Region, 2019–2027 (USD Million)

Table 4 Global Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 5 Global Dercum’s Disease Market, by Distribution Channel, 2019–2027(USD Million)

Table 6 Global Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 7 North America: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 8 North America: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 9 North America: Dercum’s Disease Market, by End-User, 2019–2027 (USD

Million)

Table 10 US: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 11 US: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)

Table 12 US: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 13 Canada: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 14 Canada: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)

Table 15 Canada: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 16 South America: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 17 South America: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 18 South America: Dercum’s Disease Market, by End-User, 2019–2027 (USD

Million)

Table 19 Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 20 Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)

Table 21 Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 22 Western Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 23 Western Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 24 Western Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD

Million)

Table 25 Eastern Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 26 Eastern Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 27 Eastern Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD

Million)

Table 28 Asia-Pacific: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 29 Asia-Pacific: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 30 Asia-Pacific: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 31 Middle East & Africa: Dercum’s Disease Market, by Treatment, 2019–2027

(USD Million)

Table 32 Middle East & Africa: Dercum’s Disease Market, by Distribution Channel, 2019–2027

(USD Million)

Table 33 Middle East & Africa: Dercum’s Disease Market, by End-User, 2019–2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Dercum’s Disease Market

Figure 3 Segmentation Market Dynamics for Global Dercum’s Disease Market

Figure 4 Global Dercum’s Disease Market Share, by Treatment, 2019

Figure 5 Global Dercum’s Disease Market Share, by Distribution Channel, 2019

Figure 6 Global Dercum’s Disease Market Share, by End-User, 2019

Figure 7 Global Dercum’s Disease Market Share, by Region, 2019

Figure 8 North America: Dercum’s Disease Market Share, by Country, 2019

Figure 9 Europe: Dercum’s Disease Market Share, by Country, 2019

Figure 10 Asia-Pacific: Dercum’s Disease Market Share, by Country, 2019

Figure 11 Middle East & Africa: Dercum’s Disease Market Share, by Country, 2019

Figure 12 Global Dercum’s Disease Market: Company Share Analysis, 2019 (%)

Figure 13 Pfizer, Inc.: Key Financials

Figure 14 Pfizer, Inc.: Segmental Revenue

Figure 15 Pfizer, Inc.: Geographical Revenue

Figure 16 AbbVie, Inc.: Key Financials

Figure 17 AbbVie, Inc.: Segmental Revenue

Figure 18 AbbVie, Inc.: Geographical Revenue

Figure 19 Merck & Co., Inc.: Key Financials

Figure 20 Merck & Co., Inc.: Segmental Revenue

Figure 21 Merck & Co., Inc.: Geographical Revenue

Figure 22 Johnson & Johnson Services, Inc.: Key Financials

Figure 23 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 24 Johnson & Johnson Services, Inc.: Geographical Revenue

Figure 25 GlaxoSmithKline plc: Key Financials

Figure 26 GlaxoSmithKline plc: Segmental Revenue

Figure 27 GlaxoSmithKline Plc. Geographical Revenue

Figure 28 Novartis: Key Financials

Figure 29 Novartis: Segmental Revenue

Figure 30 Novartis: Geographical Revenue

Figure 31 Acorda Therapeutics, Inc.: Key Financials

Figure 32 Acorda Therapeutics, Inc.: Segmental Revenue

Figure 33 Acorda Therapeutics, Inc.: Geographical Revenue

Figure 34 F. Hoffman La Roche AG: Key Financials

Figure 35 F. Hoffman La Roche AG: Segmental Revenue

Figure 36 F. Hoffman La Roche AG: Geographical Revenue

Figure 37 Eli Lily and Company: Key Financials

Figure 38 Eli Lily and Company: Segmental Revenue

Figure 39 Eli Lily and Company: Geographical Revenue

Figure 40 AstraZeneca Plc: Key Financials

Figure 41 AstraZeneca Plc: Segmental Revenue

Figure 42 AstraZeneca Plc: Geographical Revenue

Figure 43 Amgen: Key Financials

Figure 44 Amgen: Segmental Revenue

Figure 45 Amgen: Geographical Revenue

Figure 43 Valeant Pharmaceuticals: Key Financials

Figure 44 Valeant Pharmaceuticals: Segmental Revenue

Figure 45 Valeant Pharmaceuticals: Geographical Revenue

Figure 46 Syneron Medical: Key Financials

Figure 47 Syneron Medical: Segmental Revenue

Figure 48 Syneron Medical: Geographical Revenue

Figure 49 St. Jude Medical Inc.: Key Financials

Figure 50 St. Jude Medical Inc.: Segmental Revenue

Figure 51 St. Jude Medical Inc.: Geographical Revenue

Figure 52 Alimed, Inc.: Key Financials

Figure 53 Alimed, Inc.: Segmental Revenue

Figure 54 Alimed, Inc.: Geographical Revenue